William Cooper

A Vanderbilt study finds a strong association between lower ratings for interpersonal communication skills among medical residents in their last year of training and greater likelihood of unsolicited patient complaints among doctors during their first year of employment after training. Read More

The ABIM Foundation has awarded the 2019 John A. Benson Jr., MD Professionalism Article Prize to five scholarly articles — one commentary and four research pieces — that explore physician burnout, unprofessional behavior and integrity in research. Read More

In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found. Read More

Recording and analyzing patient and family reports about rude and disrespectful behavior can identify surgeons with higher rates of surgical site infections and other avoidable adverse outcomes, according to a study led by Vanderbilt University Medical Center (VUMC) investigators in collaboration with six other major academic health systems. Read More

Vanderbilt University Medical Center is part of a 6-year, $4.4 million grant from the National Institutes of Health to improve the use of prescribed medication by sickle cell patients. Read More

Alpha Omega Alpha Honor Medical Society has named the Vanderbilt Center for Patient and Professional Advocacy (CPPA) as the sole recipient of the 2016 Edward D. Harris Professionalism Award. Read More

With a greater focus on how the health care system functions, particularly in the wake of the 2009 Affordable Care Act, Vanderbilt has adjusted its own research and teaching programs surrounding public health and health policy. Read More

Vanderbilt University Medical Center is among a handful of organizations engaged to provide expertise and data to the Sentinel System, a U.S. Food and Drug Administration program designed to monitor the safety of drugs and medical devices that have reached market. Sentinel uses electronic health records and health care billing… Read More

William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and Health Policy, testified Tuesday before the U.S. Senate Health, Education, Labor and Pensions (HELP) committee regarding psychotropic medications and treatments for Attention Deficit Hyperactivity Disorder (ADHD). Read More

William O. Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics, professor and vice chair for Faculty Affairs in the Department of Pediatrics, and professor of Health Policy, has been promoted and will have two new roles. He will now also serve as associate dean for Faculty Affairs within the Faculty Affairs & Career Development Office in the Vanderbilt University School of Medicine and as director of the Vanderbilt Center for Patient and Professional Advocacy (CPPA). Read More

A new Vanderbilt University Medical Center study shows there is no evidence that the risk of suicide differs with two commonly prescribed antidepressants prescribed to children and adolescents. Read More

Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism. Read More

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Read More

Vanderbilt University is working to train a health care workforce that will be more integrated and team-oriented than ever before. One of the educational programs addressing new needs is the Vanderbilt Master of Public Health (MPH) Program, which launched a new track in Global Health last year. Read More

Attention deficit hyperactivity disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005. Read More

Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005. Read More